This content is restricted.
Brief
The Medicines and Healthcare products Regulatory Agency (MHRA) has developed a process to share operational information with UK health system partners. This applies to new active substance MAAs or variation for extension of indication applications submitted via National and International Recognition regulatory routes. The Operational Information Sharing Guidance explains the sharing purpose, nature, and consent processes. Consent is requested during MAA submission via the Human Medicines Portal.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
